These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10614178)

  • 1. [Intestinal polyposis in APC knockout mice: mechanism of tumorigenesis and chemotherapy].
    Taketo MM
    Seikagaku; 1999 Nov; 71(11):1299-308. PubMed ID: 10614178
    [No Abstract]   [Full Text] [Related]  

  • 2. [The transgenic mouse model of familial polyposis coli].
    Fehmann HC; Eissele R
    Z Gastroenterol; 1997 Nov; 35(11):1035-7. PubMed ID: 9490555
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
    Oshima M; Dinchuk JE; Kargman SL; Oshima H; Hancock B; Kwong E; Trzaskos JM; Evans JF; Taketo MM
    Cell; 1996 Nov; 87(5):803-9. PubMed ID: 8945508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 and colon cancer.
    Taketo MM
    Inflamm Res; 1998 Oct; 47 Suppl 2():S112-6. PubMed ID: 9831333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arthritis drug approved for polyp prevention blazes trail for other prevention trials.
    Smigel K
    J Natl Cancer Inst; 2000 Feb; 92(4):297-9. PubMed ID: 10675374
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclooxygenase-2 and colorectal cancer.
    DuBois RN
    Prog Exp Tumor Res; 2003; 37():124-37. PubMed ID: 12795052
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522.
    Sasai H; Masaki M; Wakitani K
    Carcinogenesis; 2000 May; 21(5):953-8. PubMed ID: 10783317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
    Steinbach G; Lynch PM; Phillips RK; Wallace MH; Hawk E; Gordon GB; Wakabayashi N; Saunders B; Shen Y; Fujimura T; Su LK; Levin B; Godio L; Patterson S; Rodriguez-Bigas MA; Jester SL; King KL; Schumacher M; Abbruzzese J; DuBois RN; Hittelman WN; Zimmerman S; Sherman JW; Kelloff G
    N Engl J Med; 2000 Jun; 342(26):1946-52. PubMed ID: 10874062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclooxygenase 2 inhibitors and colorectal cancer].
    Bernardeau-Mozer M; Chaussade S
    Bull Cancer; 2004 May; 91 Spec No():S89-98. PubMed ID: 15239336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
    Florent C; Meary N
    Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 inhibitors cut risk of colon polyps.
    Health News; 2000 Aug; 6(8):6. PubMed ID: 10948872
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
    Boolbol SK; Dannenberg AJ; Chadburn A; Martucci C; Guo XJ; Ramonetti JT; Abreu-Goris M; Newmark HL; Lipkin ML; DeCosse JJ; Bertagnolli MM
    Cancer Res; 1996 Jun; 56(11):2556-60. PubMed ID: 8653697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connexin43 is overexpressed in Apc(Min/+)-mice adenomas and colocalises with COX-2 in myofibroblasts.
    Husøy T; Knutsen HK; Cruciani V; Olstørn HB; Mikalsen SO; Løberg EM; Alexander J
    Int J Cancer; 2005 Sep; 116(3):351-8. PubMed ID: 15800939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?
    Chau I; Cunningham D
    N Engl J Med; 2002 Apr; 346(14):1085-7. PubMed ID: 11932478
    [No Abstract]   [Full Text] [Related]  

  • 17. [Familial adenomatous polyposis (FAP)--diagnosis and management].
    Gondo N; Nakagawa K; Yanagi H; Yamamura T
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):532-8. PubMed ID: 11977536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
    Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction.
    Saito T; Rodger IW; Hu F; Shennib H; Giaid A
    Biochem Biophys Res Commun; 2000 Jul; 273(2):772-5. PubMed ID: 10873679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colorectal cancer and inhibition of cyclooxygenase-2].
    Geissler M; Mohr L; Blum HE
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.